Expand LGVN Menu
LGVN MENU

LGVN Latest Press Releases

-- December 29, 2025 --

Longeveron, Selected as a StartUp Health Alzheimer's Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026 Globe Newswire 9:15 AM

-- December 17, 2025 --

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy Globe Newswire 9:15 AM

-- December 3, 2025 --

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum Globe Newswire 9:15 AM

-- December 2, 2025 --

Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging Globe Newswire 9:15 AM

-- December 1, 2025 --

Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer's Disease Presented at the Clinical Trials on Alzheimer's Disease Conference (CTAD 2025) Globe Newswire 12:00 PM

-- November 19, 2025 --

Longeveron Laromestrocel Data in Alzheimer's Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD 2025) Globe Newswire 9:15 AM

-- November 12, 2025 --

Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy Globe Newswire 9:05 AM

-- November 4, 2025 --

Longeveron Announces Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- October 28, 2025 --

Longeveron to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 Globe Newswire 9:15 AM

-- October 27, 2025 --

Longeveron Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect Globe Newswire 9:15 AM

-- October 6, 2025 --

Longeveron to Participate in the 4th Annual ROTH Healthcare Opportunities Conference Globe Newswire 9:15 AM

-- October 1, 2025 --

George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron Board of Directors Globe Newswire 4:05 PM

-- September 22, 2025 --

Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa Globe Newswire 9:15 AM

-- September 3, 2025 --

Longeveron Announces Key Leadership Updates Globe Newswire 4:05 PM

-- August 31, 2025 --

Longeveron Inc. Earnings Call: Progress Amid Challenges TipRanks 8:37 PM

-- August 20, 2025 --

Longeveron to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 9:15 AM

-- August 13, 2025 --

Longeveron Announces Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- August 11, 2025 --

Longeveron Announces Closing Of Up To $17.5 Million Public Offering Globe Newswire 4:15 PM

-- August 8, 2025 --

Longeveron Announces Up To $17.5 Million Public Offering Globe Newswire 1:28 PM

-- August 5, 2025 --

Longeveron to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025 Globe Newswire 9:15 AM
Market Data Delayed 15 Minutes